Install
Drug Discovery & Trials
Targets, biomarkers, AI discovery, and Phases I–III clinical results.
- 19 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Drug Discovery & Trials
How Charlottesville became home to more than 250 life science companies
5+ hour, 19+ min ago (170+ words) Ten years ago, a group of scientists and entrepreneurs in Charlottesville decided the community needed a way to jump start companies that could improve health. “Connecting people to one another for everything that they need – talent, capital, infrastructure, attract others…...
Anthropic touts AI-led biology discovery
3+ hour, 3+ min ago (878+ words) US artificial intelligence startup Anthropic on Wednesday unveiled the first discovery from its molecular biology lab, a previously unknown enzyme system spotted by its Claude model and touted by the company as proof that AI can speed up basic research....
New AI tool maps single cells onto tissue space with unprecedented
2+ min ago (706+ words) One of the most stubborn problems in modern genomics has finally been given a serious new contender. Single-cell RNA sequencing can catalog the gene activity of thousands of individual cells, revealing cell types in astonishing detail, but it destroys the…...
Digital Twins For Clinical Trial Protocols: From Protocol Design To Predictive Study Execution
6+ hour, 31+ min ago (207+ words) Digital Twins For Clinical Trial Protocols From Protocol Design To Predictive Study Execution Clinical Leader Digital Twins For Clinical Trial Protocols: From Protocol Design To Predictive Study Execution By Luca Parisi, Director of Data Science; Bianca De Blasi, Lead Data…...
ArcaScience brings an AI lens to drug benefit-risk tradeoffs
6+ hour, 51+ min ago (10+ words) FirstWord...
AI drug discovery startup Basecamp Research raises $140M
6+ hour, 36+ min ago (424+ words) UPDATED 16:42 EDT / SEPTEMBER 23 2026 Basecamp Research Ltd. today announced that it has raised $140 million in funding from a group of prominent investors. S32, a fund affiliated with Google LLC co-founder Bill Maris, led the Series C round. It was joined by more…...
ARCT: Phase 2 data for ARCT-810 in OTC deficiency and mRNA platform update to be presented
13+ hour, 14+ min ago (78+ words) tradingview.com ARCT: Phase 2 data for ARCT-810 in OTC deficiency and mRNA platform update to be presented A virtual presentation will detail Phase 2 data for ARCT-810 in OTC deficiency and update on the mRNA liver therapeutics platform. ARCT-810 aims to…...
New Liposome Design Could Provide Effective Slow-Release Drug Delivery System
2+ hour, 49+ min ago (471+ words) A slow-release liposome system delivered local anesthesia for weeks in rats, potentially enabling longer-lasting nerve blocks and new approaches to pain management. The post New Liposome Design Could Provide Effective Slow-Release Drug Delivery System appeared first on GEN - Genetic Engineering…...
Nvidia Opens Israel AI Lab Aimed at Faster Drug and Medical Discoveries
14+ hour, 37+ min ago (407+ words) VINnews TEL AVIV (VINnews) — Nvidia has launched a new research group in Israel that will use artificial intelligence to speed work in medicine, drug development and related science, Israeli news outlets reported Wednesday. The unit, called Applied AI Architecture, sits…...
XtalPi-Backed Viva-Thera Advances AI-Designed HIV Candidate to Preclinical Stage in Seven Months
1+ day, 1+ min ago (198+ words) 23 September 2026 | Wednesday | News MPER forms part of the membrane-fusion machinery that HIV uses to enter cells. Together with the adjacent transmembrane domain, it retains approximately 90% sequence identity across viral strains, making it an attractive target for broad-spectrum intervention. Its position…...